Publication | Open Access
Betulinic acid derivative BA5, a dual NF-kB/calcineurin inhibitor, alleviates experimental shock and delayed hypersensitivity
28
Citations
30
References
2017
Year
Molecular PharmacologyAllergyDual Nf-kb/calcineurin InhibitorMedicineImmunologyMechanism Of ActionTherapeutic EfficacyHypersensitivityExperimental TherapeuticExperimental PharmacologyPharmacotherapyPharmacologyDrug DiscoveryExperimental Shock
| Year | Citations | |
|---|---|---|
Page 1
Page 1